Evidence map›Paper›PMID 32516131›Full record

ArticleAging2020

P22077 inhibits LPS-induced inflammatory response by promoting K48-linked ubiquitination and degradation of TRAF6.

Xi-Bao Zhao, Fei-Yang Ji, Hong-Rui Li, Hui-Hui Zhu, Zi-Zhao Zhao, Jing Ling, Qian-Qian Di, Xing-Yu Ma, Wei-Lin Chen

Open access · greenAbstract read
In one paragraph

Article in Aging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Pharmacological targeting of adaptor proteins in chronic inflammation.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2024
    Review
  15. Review
  16. Inhibitory Effect of P22077 on Airway Inflammation in Rats with COPD and Its Mechanism.International journal of chronic obstructive pulmonary disease · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Xi-Bao ZhaoGuangdong Provincial Key Laboratory of Regional Immunity and Diseases, Department of Immunology, Shenzhen University School of Medicine, Shenzhen 518060, China.
Fei-Yang JiInstitute of Immunology, Zhejiang University School of Medicine, Hangzhou 310006, China.
Hong-Rui LiGuangdong Provincial Key Laboratory of Regional Immunity and Diseases, Department of Immunology, Shenzhen University School of Medicine, Shenzhen 518060, China.
Hui-Hui ZhuInstitute of Immunology, Zhejiang University School of Medicine, Hangzhou 310006, China.
Zi-Zhao ZhaoInstitute of Immunology, Zhejiang University School of Medicine, Hangzhou 310006, China.
Jing LingInstitute of Immunology, Zhejiang University School of Medicine, Hangzhou 310006, China.
Qian-Qian DiGuangdong Provincial Key Laboratory of Regional Immunity and Diseases, Department of Immunology, Shenzhen University School of Medicine, Shenzhen 518060, China.
Xing-Yu MaGuangdong Provincial Key Laboratory of Regional Immunity and Diseases, Department of Immunology, Shenzhen University School of Medicine, Shenzhen 518060, China.
Wei-Lin ChenGuangdong Provincial Key Laboratory of Regional Immunity and Diseases, Department of Immunology, Shenzhen University School of Medicine, Shenzhen 518060, China.
Zhejiang University · CNShenzhen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammation is a biological process associated with multiple human disorders such as autoimmune diseases and metabolic diseases. Therefore, alleviation of inflammation is important for disease prevention or treatment. Recently, deubiquitinating enzymes (DUBs), especially ubiquitin specific protease-7 (USP7) attracts increasing attention as a potential drug target for inflammation. As an inhibitor of USP7, P22077 has been used to study the roles of USP7 in inflammatory response and neuroblastoma growth. However, the role and precise mechanism of P22077 in anti-inflammatory is still indistinct. In this study, we demonstrated that P22077 could attenuate the release of pro-inflammatory factors including TNF-α, IL-1β, IL-6 and NO, suppress mRNA expression of COX-2 and iNOS, and inhibit activation of NF-κB and MAPKs signaling pathways in Raw264.7 cells and mouse peritoneal macrophages after LPS stimulation.

Indexed as

AnimalsAnti-Inflammatory AgentsCyclooxygenase 2CytokinesFemaleInflammationLipopolysaccharidesMacrophagesMiceMice, Inbred C57BLNF-kappa BNitric Oxide Synthase Type IIRAW 264.7 CellsSignal TransductionThiophenesTNF Receptor-Associated Factor 61-(5-((2,4-difluorophenyl)thio)-4-nitrothiophen-2-yl)ethanoneAnti-Inflammatory AgentsCyclooxygenase 2CytokinesLipopolysaccharidesNF-kappa BNitric Oxide Synthase Type IINos2 protein, mousePtgs2 protein, mouseThiophenesTNF Receptor-Associated Factor 6TRAF6 protein, mouseUbiquitin-Specific Peptidase 7inflammationP22077tumor necrosis factor receptor-associated factor 6ubiquitinationubiquitin specific protease-7

Identifiers

PMID32516131
PMCPMC7346011
OpenAlexW3033253541

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.